"Because many of the immune cells are being killed off, there's an immune reset following the treatment," Nash said. Nash and his colleagues came up with the idea based on similar treatment that blood cancer patients receive. "We knew what a profound effect the high-dose therapy and transp...
Dr. Jon LaPook goes inside the trial and approval process for an experimental treatment using stem cells designed to make Multiple Sclerosis patients better. Current treatments only try to stop the progression of the disease.Jan 21, 2014
Over the course of a month, researchers expanded stem cells derived from the fat until there were more than 100 million cells. They then injected the cells into the patient’s spine in the lower back. Seven of the 10 patients improved as a result of the injections, researc...
Currently, there is only one drug for the disease, and it slows the progression but does not halt it, said the study. Not only do the brain stem cells from primary progressive MS patients look older, they also act older, the team found. ...
Let’s hope, however, that the RMAT program brings us a little closer to the day when stem cells can be used to treat our disease. You’re invited to visit my personal blog at www.themswire.com. Also, check out our new MS forums section, the place for MS conversation. *** Note:...
Finally, the HSCs are infused back into the patient to repopulate the immune system with healthy cells.The procedure usually involves several weeks spent in a hospital. Before going home, patients have to wait for the HSCs to settle in the bone marrow and start producing healthy immune cells ...
Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in the clinic for approximately 10 years. From animal models to clinical trials, MSCs have afforded promise in the treatment of numerous diseases, mainly tissue injury and immune disorders. In this review, we...
Stem cells: BMCs are not effective to treat patients with STEMIdoi:10.1038/nrcardio.2013.193NoneNature Reviews Cardiology
Researchers found that of 174 MS patients who underwentstem cell transplants—withcellsfrom their own blood—two-thirds had no evidence of "disease activity" over 10 years. That meant no symptom relapses, no worsening disability and no signs of new damage in theirbrain tissue. In fact, of p...
Scientists have improved upon their own previous world-best efforts to pluck out just the right stem cells to address the brain problem at the core of multiple sclerosis and a large number of rare, fatal children's diseases.